COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.
Jörg Bernhard SchulzPeter BerlitHans-Christoph DienerChristian GerloffAndreas GreinacherChristine KleinGabor C PetzoldMarco PiccininniSven PoliRainer RöhrigHelmuth SteinmetzThomas ThieleTobias Kurthnull nullPublished in: Annals of neurology (2021)
Given an incidence of 0.02 to 0.15 per 100,000 person-months for CVT in the general population, these findings point toward a higher risk for CVT after ChAdOx1 vaccination, especially for women. ANN NEUROL 2021;90:627-639.